158 related articles for article (PubMed ID: 3053559)
1. Correlation between serogroup and susceptibility to chloramphenicol, clindamycin, erythromycin, rifampicin and tetracycline among 308 isolates of Clostridium difficile.
Delmée M; Avesani V
J Antimicrob Chemother; 1988 Sep; 22(3):325-31. PubMed ID: 3053559
[TBL] [Abstract][Full Text] [Related]
2. Correlation between susceptibility to chloramphenicol, tetracycline and clindamycin, and serogroups of Clostridium difficile.
Nakamura S; Yamakawa K; Nakashio S; Kamiya S; Nishida S
Med Microbiol Immunol; 1987; 176(2):79-82. PubMed ID: 3574240
[TBL] [Abstract][Full Text] [Related]
3. Studies on the resistance of Clostridium difficile to antimicrobial agents.
Wüst J; Hardegger U
Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Jan; 267(3):383-94. PubMed ID: 3376619
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility of Clostridium difficile from different sources.
Nakamura S; Nakashio S; Mikawa M; Yamakawa K; Okumura S; Nishida S
Microbiol Immunol; 1982; 26(1):25-30. PubMed ID: 7087801
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic susceptibility of Clostridium difficile isolates from adult patients at two Jamaican hospitals. Clinical and epidemiological implications.
Heslop OD; King SD; Levett PN; Barton EN; Wynter J
West Indian Med J; 2001 Mar; 50(1):50-4. PubMed ID: 11398289
[TBL] [Abstract][Full Text] [Related]
6. Transferable resistance to clindamycin, erythromycin, and tetracycline in Clostridium difficile.
Wüst J; Hardegger U
Antimicrob Agents Chemother; 1983 May; 23(5):784-6. PubMed ID: 6870225
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance in European Clostridium difficile clinical isolates.
Spigaglia P; Barbanti F; Mastrantonio P;
J Antimicrob Chemother; 2011 Oct; 66(10):2227-34. PubMed ID: 21771851
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic susceptibility of Clostridium species isolated from human infections.
Dornbusch K; Nord CE; Dahlbäck A
Scand J Infect Dis; 1975; 7(2):127-34. PubMed ID: 170668
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility testing of pneumococci: determination of Kirby-Bauer breakpoints for penicillin G, erythromycin, clindamycin, tetracycline, chloramphenicol, and rifampin.
Jacobs MR; Mithal Y; Robins-Browne RM; Gaspar MN; Koornhof HJ
Antimicrob Agents Chemother; 1979 Aug; 16(2):190-7. PubMed ID: 39493
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997.
Barbut F; Decré D; Burghoffer B; Lesage D; Delisle F; Lalande V; Delmée M; Avesani V; Sano N; Coudert C; Petit JC
Antimicrob Agents Chemother; 1999 Nov; 43(11):2607-11. PubMed ID: 10543736
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of disk diffusion method for testing the rifampicin, erythromycin, and tetracycline susceptibility of Clostridioides (prev. Clostridium) difficile.
Carvalho GM; Silva BA; Xavier RGC; Zanon IP; Vilela EG; Nicolino RR; Tavares GC; Silva ROS
Anaerobe; 2023 Apr; 80():102720. PubMed ID: 36934966
[TBL] [Abstract][Full Text] [Related]
12. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
Gosbell IB; Fernandes LA; Fernandes CJ
Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
[TBL] [Abstract][Full Text] [Related]
13. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals.
Johnson S; Samore MH; Farrow KA; Killgore GE; Tenover FC; Lyras D; Rood JI; DeGirolami P; Baltch AL; Rafferty ME; Pear SM; Gerding DN
N Engl J Med; 1999 Nov; 341(22):1645-51. PubMed ID: 10572152
[TBL] [Abstract][Full Text] [Related]
14. Regression line analysis for five antibiotics with strains of Clostridium species.
Dornbusch K; Nord CE; Olsson B
Scand J Infect Dis; 1975; 7(2):135-9. PubMed ID: 170669
[TBL] [Abstract][Full Text] [Related]
15. [Transferable tetracycline resistance in "Clostridium difficile" (author's transl)].
Ionesco H
Ann Microbiol (Paris); 1980; 131A(2):171-9. PubMed ID: 6247949
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of Clostridium difficile isolates to 12 antimicrobial agents.
Gianfrilli P; Luzzi I; Pantosti A; Occhionero M
Chemioterapia; 1984 Feb; 3(1):41-4. PubMed ID: 6535652
[TBL] [Abstract][Full Text] [Related]
17. Lincomycin and clindamycin: their role in chemotherapy of anaerobic and microaerophilic infections.
Savage GM
Infection; 1974; 2(3):152-9. PubMed ID: 4606764
[No Abstract] [Full Text] [Related]
18. Mechanism of antimicrobial resistance and resistance transfer in anaerobic bacteria.
Tally FP; Malamy MH
Scand J Infect Dis Suppl; 1982; 35():37-44. PubMed ID: 6300995
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from the Chinese People's Liberation Army General Hospital in China.
Wang R; Suo L; Chen HX; Song LJ; Shen YY; Luo YP
Int J Infect Dis; 2018 Feb; 67():86-91. PubMed ID: 28736259
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis.
Dzink J; Bartlett JG
Antimicrob Agents Chemother; 1980 Apr; 17(4):695-8. PubMed ID: 7396460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]